美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=NINTEDANIB"
符合检索条件的记录共 19 条
共 1 页，当前第 1 页
返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
NINTEDANIB 212732 001 ANDA NINTEDANIB CAPSULE;ORAL EQ 100MG BASE No No 2020/08/04 (TA) -- ACCORD HLTHCARE INC None (Tentative Approval)
NINTEDANIB 212732 002 ANDA NINTEDANIB CAPSULE;ORAL EQ 150MG BASE No No 2020/08/04 (TA) -- ACCORD HLTHCARE INC None (Tentative Approval)
NINTEDANIB 215123 002 ANDA NINTEDANIB CAPSULE;ORAL EQ 150MG BASE No No 2026/02/04 (TA) -- EUGIA PHARMA SPECLTS None (Tentative Approval)
NINTEDANIB 218472 002 ANDA NINTEDANIB CAPSULE 100MG No No 2026/03/05 (TA) -- HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD None (Tentative Approval)
NINTEDANIB 218472 003 ANDA NINTEDANIB CAPSULE 25MG No No 2026/03/05 (TA) -- HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD None (Tentative Approval)
NINTEDANIB 219708 002 ANDA NINTEDANIB CAPSULE 100MG No No 2026/03/17 (TA) -- QILU PHARMACEUTICAL CO., LTD. None (Tentative Approval)
NINTEDANIB 212555 002 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2026/03/26 (TA) -- GLENMARK PHARMS LTD None (Tentative Approval)
NINTEDANIB 219371 002 ANDA NINTEDANIB CAPSULE 100MG No No 2026/03/26 (TA) -- TEVA PHARMACEUTICALS DEVELOPMENT INC None (Tentative Approval)
NINTEDANIB 219371 003 ANDA NINTEDANIB CAPSULE 25MG No No 2026/03/26 (TA) -- TEVA PHARMACEUTICALS DEVELOPMENT INC None (Tentative Approval)
NINTEDANIB ESYLATE 212609 001 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 100MG BASE No No 2026/04/02 2026/04/02 CIPLA Prescription
NINTEDANIB ESYLATE 212609 002 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2026/04/02 2026/04/02 CIPLA Prescription
NINTEDANIB ESYLATE 216915 001 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 100MG BASE No No 2026/04/02 2026/04/02 SANDOZ Prescription
NINTEDANIB ESYLATE 216915 002 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2026/04/02 2026/04/02 SANDOZ Prescription
NINTEDANIB ESYLATE 219227 001 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 100MG BASE No No 2026/04/02 2026/04/02 APOTEX Prescription
NINTEDANIB ESYLATE 219227 002 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2026/04/02 2026/04/02 APOTEX Prescription
NINTEDANIB ESYLATE 219283 001 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 100MG BASE No No 2026/04/02 2026/04/02 DR REDDYS Prescription
NINTEDANIB ESYLATE 219283 002 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2026/04/02 2026/04/02 DR REDDYS Prescription
NINTEDANIB ESYLATE 219819 001 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 100MG BASE No No 2026/04/02 2026/04/02 DEXCEL Prescription
NINTEDANIB ESYLATE 219819 002 ANDA NINTEDANIB ESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2026/04/02 2026/04/02 DEXCEL Prescription
药品名称，活性成分，申请号搜索 高级检索
©2006-2026 DrugFuture->U.S. FDA Drugs Database